UKOM Sp.KJ flashcards
UKOM Sp.KJ · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Mesolimbic pathway
- Dopamine projection from ventral tegmental area to nucleus accumbens and limbic structures; hyperactivity is linked to positive psychotic symptoms and reward dysregulation.
- Tuberoinfundibular pathway
- Dopamine neurons from arcuate nucleus to pituitary that inhibit prolactin release; blockade by antipsychotics causes hyperprolactinemia with galactorrhea and amenorrhea.
- Neuroleptic malignant syndrome
- Life-threatening reaction to dopamine antagonists with rigidity, hyperthermia, autonomic instability, and raised creatine kinase; treat by stopping the drug and giving dantrolene or bromocriptine.
- Serotonin syndrome
- Toxic excess of serotonergic activity causing clonus, hyperreflexia, agitation, and hyperthermia; commonly from SSRI combined with MAOI, tramadol, or linezolid.
- First-rank symptoms
- Schneiderian phenomena including audible thoughts, voices arguing, thought insertion or withdrawal, made feelings, and delusional perception; historically suggestive of schizophrenia.
- Flight of ideas
- Rapid speech with frequent topic shifts still linked by understandable associations; typical of mania rather than the incoherence of schizophrenia.
- Overvalued idea
- A solitary, understandable belief pursued with less rigidity than a delusion; often seen in personality disorders and not by itself diagnostic of psychosis.
- Decision-making capacity
- Ability to understand relevant information, retain it, weigh it in a decision, and communicate a choice; assessed for a specific decision at a specific time.
- Schizophreniform disorder
- Psychotic disorder with schizophrenia symptoms lasting at least one month but less than six months; prognosis is better than schizophrenia and treatment is similar.
- Schizoaffective disorder
- Illness with a major mood episode plus psychotic symptoms, where delusions or hallucinations persist for at least two weeks without mood symptoms.
- Tardive dyskinesia
- Involuntary oro-facial and limb movements appearing after months to years of dopamine antagonist exposure; treat with VMAT2 inhibitors such as valbenazine.
- Catatonia
- Syndrome of psychomotor abnormality with stupor, catalepsy, mutism, negativism, or posturing; treat with benzodiazepines and ECT if refractory.
- Mixed features specifier
- Presence of subthreshold opposite-polarity symptoms during a mood episode, such as manic symptoms during depression; raises suicide risk and restricts antidepressant monotherapy.
- Rapid cycling
- Four or more mood episodes within twelve months in bipolar disorder; associated with female sex, thyroid disease, and antidepressant use; treat with mood stabilizer.
- Treatment-resistant depression
- Failure of at least two adequate antidepressant trials in dose and duration; next steps include lithium or atypical antipsychotic augmentation, ECT, or esketamine.
- Panic attack
- Abrupt surge of intense fear peaking within minutes with palpitations, dyspnea, choking, dizziness, and fear of dying or losing control.
- Post-traumatic stress disorder
- Trauma-related disorder with intrusion, avoidance, negative cognitions, and hyperarousal lasting over one month; trauma-focused psychotherapy is first-line.
- Exposure and response prevention
- Behavioural therapy for OCD where patients face feared triggers and refrain from rituals; first-line alongside high-dose SSRI.
- Alcohol withdrawal delirium
- Delirium tremens occurring 48 to 96 hours after alcohol cessation with confusion, tremor, sweating, and tachycardia; treat with benzodiazepines and thiamine.
- Wernicke encephalopathy
- Thiamine deficiency causing confusion, ataxia, and ophthalmoplegia; give parenteral thiamine before glucose to prevent Korsakoff syndrome.
- Naloxone
- Short-acting opioid antagonist used for overdose with respiratory depression; repeated doses or infusion may be needed because its half-life is shorter than most opioids.
- Delirium
- Acute fluctuating disturbance of attention and awareness due to a medical cause; manage by treating the cause and using environmental measures before antipsychotics.
- Lewy body dementia
- Dementia with fluctuating cognition, visual hallucinations, parkinsonism, and REM sleep behaviour disorder; severe neuroleptic sensitivity means avoiding typical antipsychotics.
- Frontotemporal dementia
- Neurodegeneration with behavioural disinhibition, apathy, or language impairment; cholinesterase inhibitors are generally ineffective and may worsen behaviour.
- ADHD diagnostic threshold
- At least six inattention or hyperactivity-impulsivity symptoms before age twelve, across two settings; five suffice for those aged seventeen or older.
- Autism spectrum disorder
- Developmental disorder with persistent social communication deficits and restricted, repetitive behaviours; early behavioural intervention improves function and no biomedical cure exists.
- Tourette disorder
- Multiple motor tics plus at least one vocal tic for over a year; often comorbid with ADHD and OCD; treat with behavioural therapy or alpha-2 agonists.
- Pseudodementia
- Depressive cognitive impairment in older adults with prominent complaints, variable performance, and improvement after treating depression; unlike dementia, effort fluctuates.
- Beers criteria
- List of medications potentially inappropriate in older adults, including benzodiazepines and anticholinergics, because of falls, fractures, and delirium risk.
- Dialectical behaviour therapy
- Structured therapy teaching mindfulness, distress tolerance, emotion regulation, and interpersonal skills; first-line for borderline personality disorder and repeated self-harm.
- Motivational interviewing
- Collaborative, autonomy-supportive counselling style using open questions, affirmations, reflections, and summaries to elicit the patient's own change talk.
- Involuntary admission criteria
- Detention justified by serious mental disorder with risk to self or others or inability to self-care; requires review, legal representation, and least restrictive care under Indonesian Law 18/2014.